HDAC9 and amyotrophic lateral sclerosis: A riluzole, edaravone, and taurursodiol and sodium phenylbutyrate combination (relyvrio) targets excitotoxicity, oxidative stress, mitochondrial health and HDAC, respectively, in ALS [214,215,216].